Related Experiment Video
Updated: Jan 9, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Multi-Target Botanical Complex Attenuates Cellular Senescence via Bidirectional P21/P53/SIRT1 Regulation: Dual Model
Jiaqin Wu1, Nanjia Dongzhu2, Chengzhou Zhao2
1College of Pharmacy, Qinghai University, Xining 810016, China.
Abstract:
Cellular senescence is a pivotal driver of aging and age-related diseases. This study aims to systematically investigate the anti-senescence effects and molecular mechanisms of a multi-component botanical complex (SBT) using both a D-galactose-induced senescence model in H9c2 cardiomyocytes and an H2O2-induced accelerated aging model in zebrafish. The SBT complex comprises Solms-laubachia eurycarpa, Bergenia purpurascens, Laccifer lacca, and Glycyrrhiza uralensis. Results demonstrated that SBT treatment significantly enhanced cell viability (increased from 52% to 85%) and reduced senescence-associated β-galactosidase (SA-β-gal) activity (from 41.2% to 20%). At the molecular level, SBT exerted bidirectional regulation of the P21/P53/SIRT1 axis, coordinately downregulating the pro-senescence proteins P53 and P21 while upregulating the longevity-associated deacetylase SIRT1. It also modulated the balance of apoptosis-related genes by suppressing Bax and enhancing Bcl-2 expression. In the zebrafish model, SBT significantly strengthened the antioxidant defense system, as indicated by increased activities of superoxide dismutase (SOD) and catalase (CAT), elevated glutathione (GSH) levels, and reduced malondialdehyde (MDA) content. These findings confirm that SBT exerts potent anti-senescence effects through bidirectional regulation of the P21/P53/SIRT1 signaling axis, enhanced antioxidant capacity, and inhibition of apoptosis, thereby providing a mechanistic foundation for the development of natural product-based interventions against aging and related diseases.
Insights
A botanical complex (SBT) combats cellular senescence, a key aging factor. SBT enhances cell viability and antioxidant defenses, offering potential natural interventions for age-related diseases.
Area of Science:
- Gerontology and cellular biology
- Natural product chemistry
- Molecular mechanisms of aging
Background:
- Cellular senescence is a significant contributor to aging and age-related diseases.
- Identifying natural compounds with anti-senescence properties is crucial for developing interventions.
- Existing research highlights the need for understanding the molecular pathways involved in senescence.
Purpose of the Study:
- To investigate the anti-senescence effects of a multi-component botanical complex (SBT).
- To elucidate the molecular mechanisms underlying SBT's anti-senescence activity.
- To evaluate SBT in both in vitro and in vivo aging models.
Main Methods:
- Utilized D-galactose-induced senescence in H9c2 cardiomyocytes and H2O2-induced accelerated aging in zebrafish.
- Assessed cell viability and senescence-associated β-galactosidase (SA-β-gal) activity.
- Analyzed the P21/P53/SIRT1 signaling axis, apoptosis-related genes (Bax, Bcl-2), and antioxidant enzyme activities (SOD, CAT, GSH, MDA).
Main Results:
- SBT significantly improved cell viability and reduced SA-β-gal activity in senescent cells.
- SBT demonstrated bidirectional regulation of the P21/P53/SIRT1 axis, downregulating P53/P21 and upregulating SIRT1.
- SBT enhanced antioxidant capacity in zebrafish by increasing SOD, CAT, and GSH, while decreasing MDA, and modulated apoptosis markers (Bax/Bcl-2).
Conclusions:
- SBT exhibits potent anti-senescence effects.
- The mechanisms involve regulating the P21/P53/SIRT1 pathway, boosting antioxidant defense, and inhibiting apoptosis.
- SBT provides a mechanistic basis for natural product-based anti-aging therapies.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Replicative Cell Senescence
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle

